Your browser doesn't support javascript.
loading
Evaluation of Adverse Effects in Nursing Mothers and Their Infants After COVID-19 mRNA Vaccination.
Romero Ramírez, Dolores Sabina; Suárez Hernández, María Isis; Fernández Vilar, Ana María; Rivero Falero, Mónica; Reyes Millán, Beatriz; González Carretero, Paloma; Pérez, María Magdalena Lara; Carretero Pérez, Mercedes; Martín Pulido, Saúl; Pera Villacampa, Lorena; García Bello, Miguel Ángel; Mesa Medina, Orlando Manuel; Roper, Sabine.
Afiliación
  • Romero Ramírez DS; Department of Pediatrics, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Suárez Hernández MI; Department of Obstetrics and Gynecology, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Fernández Vilar AM; Department of Obstetrics and Gynecology, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Rivero Falero M; Department of Pediatrics, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Reyes Millán B; Department of Pediatrics, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • González Carretero P; Department of Pediatrics, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Pérez MML; Department of Laboratory and Clinical Analysis, Clinical Microbiology Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Carretero Pérez M; Department of Laboratory and Clinical Analysis, Clinical Analysis Laboratory, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Martín Pulido S; Department of Pediatrics, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Pera Villacampa L; Department of Obstetrics and Gynecology, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • García Bello MÁ; University of La Laguna, La Laguna, Spain.
  • Mesa Medina OM; Department of Pediatrics, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Roper S; Department of Pediatrics, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Breastfeed Med ; 17(5): 412-421, 2022 05.
Article en En | MEDLINE | ID: mdl-35263195
Background and Objectives: Breastfeeding women are generally excluded from clinical trials with new vaccines. The objective of the study was to explore whether the BNT162b2 mRNA and mRNA-1273 COVID-19 vaccines are safe for breastfeeding mothers and their breastfed infants. Methods: A convenience sample prospective cohort single institution study was performed on breastfeeding health care professionals, who were exposed to second dose of SARS-CoV2 vaccine at the beginning of the study period. They and their breastfed children's symptoms were followed up through online questionnaires for 14 days. Results: Of the 95 finally included participants, only 1 was lost to follow-up on day 7. Mean age of the mothers was 35.9 ± 3.9 years and that of their infants was 14.6 ± 12.1 months. At least one adverse event was reported by 85% (95% confidence interval [CI]: 76-91.5%) of the mothers. The most frequent was injection site pain in 81% of cases. Moreover, 31% (95% CI: 22-41%) observed some event in their breastfed children. Most frequently, 19% (95% CI: 13-30%) of the children were irritable. During the 14 days of follow-up, 36% of the children (95% CI: 27-46%) were diagnosed with respiratory infection. Conclusions: Most mothers' reactions were mild and transitory, generally limited to the first 3 days after vaccination. Many children's events were associated with concomitant infectious processes and we did not detect a notable peak on any particular day of follow-up. Neither mothers nor their infants developed serious adverse events nor were they diagnosed with COVID-19 within the study period.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Infant Idioma: En Revista: Breastfeed Med Asunto de la revista: CIENCIAS DA NUTRICAO Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Infant Idioma: En Revista: Breastfeed Med Asunto de la revista: CIENCIAS DA NUTRICAO Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos